A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
Clinical trial NCT05202262 · COMPLETED
Trial details
- NCT number
- NCT05202262
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2025-02-26
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.